MEDSIR, a Spain-based international company specialised in the strategic design of clinical trials, announced on Thursday that it has named Jyoti Mundra, PhD as its new chief business officer.
In the new role, Dr Mundra is to provide support in expediting the company's growth while improving its presence and business in North America. She will be heading a global business and marketing team to provide clinical solutions to biopharma companies and build a network with hospitals and institutions.
Dr Mundra has served at various full service CRO's, supporting biopharma companies to advance their drug pipeline. She has held the position of a director of Business Development at Sinclair Research. She also served in similar roles at Champions Oncology and Covance.
Bioforum, The Data Masters names new President
VolitionRx names new Chief Medical Officer
Quotient Sciences announces new appointments
Syndax Pharmaceuticals names new chief commercial officer
Everest Medicines names new chief medical officer and chief product officer
D3 Bio names new independent board member
Rigel Pharmaceuticals names new executive vice president and chief medical officer
Telix Pharmaceuticals names new group chief operating officer